Compare AMH & CAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AMH | CAI |
|---|---|---|
| Founded | 2012 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Medical Specialities |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.0B | 9.7B |
| IPO Year | 2012 | 2025 |
| Metric | AMH | CAI |
|---|---|---|
| Price | $32.04 | $32.19 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 24 | 14 |
| Target Price | ★ $36.52 | $32.46 |
| AVG Volume (30 Days) | 2.4M | ★ 3.5M |
| Earning Date | 11-04-2026 | 11-04-2026 |
| Dividend Yield | ★ 4.14% | N/A |
| EPS Growth | 9.26 | ★ 69.79 |
| EPS | ★ 0.66 | N/A |
| Revenue | ★ $1,182,836,000.00 | $812,033,000.00 |
| Revenue This Year | $2.92 | $26.99 |
| Revenue Next Year | $3.50 | $19.44 |
| P/E Ratio | $48.41 | ★ N/A |
| Revenue Growth | 3.45 | ★ 96.97 |
| 52 Week Low | $27.22 | $14.19 |
| 52 Week High | $35.07 | $36.50 |
| Indicator | AMH | CAI |
|---|---|---|
| Relative Strength Index (RSI) | 57.53 | 54.31 |
| Support Level | $31.63 | $16.52 |
| Resistance Level | $32.47 | $32.73 |
| Average True Range (ATR) | 0.52 | 2.02 |
| MACD | 0.13 | 0.13 |
| Stochastic Oscillator | 76.52 | 46.88 |
American Homes 4 Rent is a real estate investment trust focused on acquiring, operating, and leasing single-family homes as rental properties throughout the United States. The company's real estate portfolio is largely comprised of single-family properties in urban markets in the Southern and Midwestern regions of the U.S. American Homes 4 Rent's land holdings also represent a sizable percentage of its total assets in terms of value. The company derives the vast majority of its income in the form of rental revenue from single-family properties through short-term or annual leases. The firm's geographical markets include Dallas, Texas; Indianapolis, Indiana; Atlanta, Georgia; and Charlotte, North Carolina in terms of the number of properties in each.
Caris Life Sciences Inc is a patient-centric, next-generation AI TechBio company. It develop and commercialize solutions to transform healthcare through the use of comprehensive molecular information and artificial intelligence/machine learning algorithms at scale.